Literature DB >> 31076852

Impact of chronic kidney disease on recurrent ventricular tachyarrhythmias in ICD recipients.

Kathrin Weidner1, Michael Behnes2, Christel Weiß3, Christoph Nienaber4, Linda Reiser1, Armin Bollow1, Gabriel Taton1, Thomas Reichelt1, Dominik Ellguth1, Niko Engelke1, Jonas Rusnak1, Tobias Schupp1, Seung-Hyun Kim1, Christian Barth1, Jorge Hoppner5, Muharrem Akin6, Kambis Mashayekhi7, Martin Borggrefe1, Ibrahim Akin1.   

Abstract

The study sought to assess the impact of chronic kidney disease (CKD) on recurrences of ventricular tachyarrhythmias in implantable cardioverter defibrillator (ICD) recipients. Data regarding the outcome of patients with CKD in ICD recipients is limited. A large retrospective registry was used including consecutive ICD recipients surviving episodes of ventricular tachycardia (VT) or fibrillation (VF) from 2002 to 2016. CKD patients were compared to non-CKD patients. The primary endpoint was the first recurrence of ventricular tachyarrhythmias at 5 years. Secondary endpoints were ICD-related therapies, rehospitalization and all-cause mortality at 5 years. Kaplan-Meier, multivariable Cox regression and propensity score matching were applied. A total of 585 consecutive patients were included (non-CKD: 57%, CKD: 43%). CKD had higher rates of the primary endpoint of recurrent ventricular tachyarrhythmias compared to non-CKD patients (50% vs. 40%; log rank p = 0.008; HR = 1.398; 95% CI 1.087-1.770; p = 0.009), which was irrespective of a primary or secondary preventive ICD and mainly attributed to recurrent VF (11% vs. 5%; p = 0.007) and electrical storm (ES) (10% vs. 5%; p = 0.010). Accordingly, CKD patients had higher rates of the secondary endpoint of appropriate ICD therapies (41% vs. 30%; log rank p = 0.002; HR = 1.532; 95% CI 1.163-2.018; p = 0.002), mainly attributed to appropriate ICD shocks (19% vs. 11%; p = 0.005). After multivariable Cox regression CKD was associated with a 1.4-fold higher risk of appropriate device therapies (HR = 1.353; 95% CI 1.001-1.825; p = 0.049), but not with first recurrence of ventricular tachyarrhythmias (p = 0.177). Irrespective of propensity score matching, CKD was associated with increasing all-cause mortality at 5 years (p = 0.001). The presence of CKD is associated with increased rates of recurrent ventricular tachyarrhythmias, appropriate device therapies, mainly attributed to appropriate shock, and all-cause mortality in ICD recipients at 5 years.

Entities:  

Keywords:  Chronic kidney disease; ICD; Mortality; Ventricular fibrillation; Ventricular tachycardia

Mesh:

Year:  2019        PMID: 31076852     DOI: 10.1007/s00380-019-01415-z

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  42 in total

1.  [Guidelines for the implantation of defibrillators].

Authors:  W Jung; D Andresen; M Block; D Böcker; S H Hohnloser; K-H Kuck; J Sperzel
Journal:  Clin Res Cardiol       Date:  2006-12       Impact factor: 5.460

2.  [2016 European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts. Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation].

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren
Journal:  G Ital Cardiol (Rome)       Date:  2017 Jul-Aug

3.  [2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death].

Authors:  Silvia G Priori; Carina Blomström-Lundqvist; Andrea Mazzanti; Nico Blom; Martin Borggrefe; John Camm; Perry Mark Elliott; Donna Fitzsimons; Robert Hatala; Gerhard Hindricks; Paulus Kirchhof; Keld Kjeldsen; Karl-Heinz Kuck; Antonio Hernandez-Madrid; Nikolaos Nikolaou; Tone M Norekvål; Christian Spaulding; Dirk J Van Veldhuisen
Journal:  Kardiol Pol       Date:  2015       Impact factor: 3.108

4.  Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients.

Authors:  Jason Robin; Kenneth Weinberg; Jay Tiongson; Mercedes Carnethon; Madhavi Reddy; Christina Ciaccio; Michael Quadrini; Jonathan Hsu; John Fan; Patrick Choi; Alan Kadish; Jeffrey Goldberger; Rod Passman
Journal:  Heart Rhythm       Date:  2006-07-08       Impact factor: 6.343

5.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.

Authors:  A J Moss; W J Hall; D S Cannom; J P Daubert; S L Higgins; H Klein; J H Levine; S Saksena; A L Waldo; D Wilber; M W Brown; M Heo
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

6.  Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States.

Authors:  David M Charytan; Amanda R Patrick; Jun Liu; Soko Setoguchi; Charles A Herzog; M Alan Brookhart; Wolfgang C Winkelmayer
Journal:  Am J Kidney Dis       Date:  2011-06-12       Impact factor: 8.860

Review 7.  Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease.

Authors:  Steven G Coca; Harlan M Krumholz; Amit X Garg; Chirag R Parikh
Journal:  JAMA       Date:  2006-09-20       Impact factor: 56.272

8.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

Review 9.  Chronic kidney disease: effects on the cardiovascular system.

Authors:  Ernesto L Schiffrin; Mark L Lipman; Johannes F E Mann
Journal:  Circulation       Date:  2007-07-03       Impact factor: 29.690

10.  Get the most from your data: a propensity score model comparison on real-life data.

Authors:  Dennis Ferdinand; Mirko Otto; Christel Weiss
Journal:  Int J Gen Med       Date:  2016-05-17
View more
  2 in total

1.  Anti-tachycardia pacing for non-fast and fast ventricular tachycardias in individual Japanese patients: From Nippon-storm study.

Authors:  Masaomi Chinushi; Osamu Saitoh; Hiroshi Furushima; Yoshifusa Aizawa; Takashi Noda; Takashi Nitta; Tohru Ohe; Takashi Kurita
Journal:  J Arrhythm       Date:  2021-06-08

2.  Chronic kidney disease impairs prognosis in electrical storm.

Authors:  Kathrin Weidner; Michael Behnes; Tobias Schupp; Jorge Hoppner; Uzair Ansari; Julian Mueller; Simon Lindner; Martin Borggrefe; Seung-Hyun Kim; Aydin Huseyinov; Dominik Ellguth; Muharrem Akin; Dirk Große Meininghaus; Thomas Bertsch; Gabriel Taton; Armin Bollow; Thomas Reichelt; Niko Engelke; Linda Reiser; Ibrahim Akin
Journal:  J Interv Card Electrophysiol       Date:  2021-01-23       Impact factor: 1.900

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.